In this regard, it is important to understand whether the MMR pathway plays a role in the repair of nitric oxide-induced-DNA damage and if so, whether the consequent accumulation of mutations has the capacity to enhance CRC development in MMR-deficient hosts. The gene discussed is MRC1; the disease is colorectal carcinoma.